Non-invasive prenatal testing (NIPT), also known as cell-free DNA (cfDNA) screening, is a targeted antenatal screening test that looks for chromosomal abnormalities. These can determine whether the baby is likely to be affected by conditions like Down's syndrome, Edwards' syndrome or Patau's syndrome.
